Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases

doi:10.1016/j.biopha.2018.12.022

Review

. 2019 Feb:110:775-785.

doi: 10.1016/j.biopha.2018.12.022. Epub 2018 Dec 13.

Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases

Asghar Fallah¹, Ali Sadeghinia², Houman Kahroba³, Amin Samadi⁴, Hamid Reza Heidari⁵, Behzad Bradaran⁶, Sirous Zeinali⁷, Ommoleila Molavi⁸

Affiliations

¹ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
² Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
³ Molecular Medicine Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
⁴ Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Canada.
⁵ Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
⁶ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
⁷ Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
⁸ Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Molecular Medicine Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: omolavi@ualberta.ca.

PMID: 30554116
DOI: 10.1016/j.biopha.2018.12.022

Free article

Review

Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases

Asghar Fallah et al. Biomed Pharmacother. 2019 Feb.

Free article

. 2019 Feb:110:775-785.

doi: 10.1016/j.biopha.2018.12.022. Epub 2018 Dec 13.

Authors

Asghar Fallah¹, Ali Sadeghinia², Houman Kahroba³, Amin Samadi⁴, Hamid Reza Heidari⁵, Behzad Bradaran⁶, Sirous Zeinali⁷, Ommoleila Molavi⁸

Affiliations

¹ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
² Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
³ Molecular Medicine Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
⁴ Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Canada.
⁵ Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
⁶ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
⁷ Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
⁸ Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Molecular Medicine Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: omolavi@ualberta.ca.

PMID: 30554116
DOI: 10.1016/j.biopha.2018.12.022

Abstract

Angiogenesis is a critical step in the progression of almost all human malignancies and some other life-threatening diseases. Anti-angiogenic therapy is a novel and effective approach for treatment of angiogenesis-dependent diseases such as cancer, diabetic retinopathy, and age-related macular degeneration. In this article, we will review the main strategies developed for anti-angiogenic therapies beside their clinical applications, the major challenges, and the latest advances in the development of anti-angiogenesis-based targeted therapies.

Keywords: Angiogenesis-dependent diseases; Anti-angiogenesis; Anti-angiogenic therapeutics; Cancer; VEGF–VEGFR system receptors.

PubMed Disclaimer

Cited by

Advances in tumor vascular growth inhibition.
Zhang K, Shi Y, Jin Z, He J. Zhang K, et al. Clin Transl Oncol. 2024 Mar 20. doi: 10.1007/s12094-024-03432-5. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38504070 Review.
The Supression of Migration and Metastasis via Inhibition of Vascular Endothelial Growth Factor in Pancreatic Adenocarcinoma Cells Applied Danusertib.
Alabaş E, Ata Özçimen A. Alabaş E, et al. Turk J Gastroenterol. 2024 Feb;35(2):150-157. doi: 10.5152/tjg.2024.22319. Turk J Gastroenterol. 2024. PMID: 38454247 Free PMC article.
Polyethylenimine Triggers Dll4 Degradation to Regulate Angiogenesis In Vitro.
Cheng B, Li Y, Ji YB, Shi W, Li M, Zheng J, Ding L, Liu K, Fang L, Xu Y, Li H, Shao X. Cheng B, et al. ACS Omega. 2024 Feb 7;9(7):7502-7510. doi: 10.1021/acsomega.3c06050. eCollection 2024 Feb 20. ACS Omega. 2024. PMID: 38405519 Free PMC article.
Secretome of bovine umbilical vein endothelial cells promote wound healing regeneration on the second degree rat model burn injury.
Moghan M, Naidu P, Zulkifly NB, Selan YN, Setyawan EMN, Winarsih S, Kusindarta DL. Moghan M, et al. Open Vet J. 2023 Dec;13(12):1597-1606. doi: 10.5455/OVJ.2023.v13.i12.9. Epub 2023 Dec 31. Open Vet J. 2023. PMID: 38292702 Free PMC article.
Protein-Protein Interactions of Seryl-tRNA Synthetases with Emphasis on Human Counterparts and Their Connection to Health and Disease.
Dulic M, Godinic-Mikulcic V, Kekez M, Evic V, Rokov-Plavec J. Dulic M, et al. Life (Basel). 2024 Jan 15;14(1):124. doi: 10.3390/life14010124. Life (Basel). 2024. PMID: 38255739 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases

Affiliations

Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources